Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
J Biotechnol ; 373: 73-81, 2023 Aug 20.
Article in English | MEDLINE | ID: mdl-37271453

ABSTRACT

The use of transposase in cell line development (CLD) programs has experienced increased popularity over the past decade. However, few studies have described the mechanism of action and the genomic and phenotypic characteristics of clones derived from transposase. Additionally, how these traits impact long-term bioproduction is unknown. Here, we use chromosome painting, deep sequencing, and ddPCR to characterize the unique fingerprints associated with transposase-derived clones. Transposase reduces the cellular pool of transient vector as early as three days post transfection following transfection and expedites stable pool establishment by up to two weeks. Furthermore, recombinant DNA expression is significantly improved up to ∼3 fold along with a greater balance of antibody heavy and light chain transcripts, resulting in higher titers in transposase generated pools. Transposase derived pools contained an often innumerable number of integration sites, representing a vast increase in integration site diversity over randomly generated pools, which were bottlenecked at 1-3 integration sites per pool. These transposase mediated integrations typically occurred in clean singlets, free of genomic scars such as deletions, inversions, and other modifications associated with legacy transfection methods which exhibited higher copy numbers per integration site. Relative declines in gene expression occur with copy number increase in the randomly generated, but not the transposase derived clones. Furthermore, transposase-derived clones were more likely to exhibit enhanced a long term stability profile, including product quality attributes such as mannose-5. This improved stability may result from circumventing mechanisms associated with the silencing of tandem repeats. Thus, transposase-mediated approaches can provide multifaceted molecular and phenotypic advantages in cell line development when compared to legacy random-integration methods.


Subject(s)
DNA Transposable Elements , Transposases , Cricetinae , Animals , Cricetulus , CHO Cells , Clone Cells , DNA Transposable Elements/genetics , Transposases/genetics , Transposases/metabolism , Genomics
2.
PLoS One ; 14(12): e0218653, 2019.
Article in English | MEDLINE | ID: mdl-31856197

ABSTRACT

Chinese hamster ovary (CHO) cells are a common tool utilized in bioproduction and directed genome engineering of CHO cells is of great interest to enhance recombinant cell lines. Until recently, this focus has been challenged by a lack of efficacious, high throughput, and low-cost gene editing modalities and screening methods. In this work, we demonstrate an improved method for gene editing in CHO cells using CRISPR RNPs and characterize the endpoints of Cas9 and ZFN mediated genetic engineering. Furthermore, we validate sequence decomposition as a cost effective, rapid, and accurate method for assessing mutants and eliminating non-clonal CHO populations using only capillary sequencing.


Subject(s)
CHO Cells/metabolism , CHO Cells/physiology , Genetic Engineering/methods , Animals , CRISPR-Cas Systems , Clustered Regularly Interspaced Short Palindromic Repeats , Cricetinae/genetics , Cricetulus , Gene Editing/methods , Genome/genetics , High-Throughput Screening Assays/methods
4.
Oncogene ; 36(33): 4750-4766, 2017 08 17.
Article in English | MEDLINE | ID: mdl-28394342

ABSTRACT

Centrosomes together with the mitotic spindle ensure the faithful distribution of chromosomes between daughter cells, and spindle orientation is a major determinant of cell fate during tissue regeneration. Spindle defects are not only an impetus of chromosome instability but are also a cause of developmental disorders involving defective asymmetric cell division. In this work, we demonstrate BCCIP, especially BCCIPα, as a previously unidentified component of the mitotic spindle pole and the centrosome. We demonstrate that BCCIP localizes proximal to the mother centriole and participates in microtubule organization and then redistributes to the spindle pole to ensure faithful spindle architecture. We find that BCCIP depletion leads to morphological defects, disoriented mitotic spindles, chromosome congression defects and delayed mitotic progression. Our study identifies BCCIP as a novel factor critical for microtubule regulation and explicates a mechanism utilized by BCCIP in tumor suppression.


Subject(s)
Calcium-Binding Proteins/metabolism , Cell Cycle Proteins/metabolism , Centrioles/metabolism , Centrosome/physiology , Microtubules/physiology , Mitosis/physiology , Nuclear Proteins/metabolism , Spindle Poles/physiology , Animals , Calcium-Binding Proteins/genetics , Cell Cycle Proteins/genetics , Chromosome Segregation/physiology , Dynactin Complex/metabolism , Dyneins/metabolism , HEK293 Cells , HeLa Cells , Humans , Mice , Microtubules/drug effects , Nocodazole/pharmacology , Nuclear Proteins/genetics , Paclitaxel/pharmacology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Tubulin Modulators/pharmacology
5.
Leukemia ; 31(8): 1735-1742, 2017 08.
Article in English | MEDLINE | ID: mdl-28025584

ABSTRACT

Immunoglobulin light chain (AL) amyloidosis is characterized by tissue deposition of amyloid fibers derived from immunoglobulin light chain. AL amyloidosis and multiple myeloma (MM) originate from monoclonal gammopathy of undetermined significance. We wanted to characterize germline susceptibility to AL amyloidosis using a genome-wide association study (GWAS) on 1229 AL amyloidosis patients from Germany, UK and Italy, and 7526 healthy local controls. For comparison with MM, recent GWAS data on 3790 cases were used. For AL amyloidosis, single nucleotide polymorphisms (SNPs) at 10 loci showed evidence of an association at P<10-5 with homogeneity of results from the 3 sample sets; some of these were previously documented to influence MM risk, including the SNP at the IRF4 binding site. In AL amyloidosis, rs9344 at the splice site of cyclin D1, promoting translocation (11;14), reached the highest significance, P=7.80 × 10-11; the SNP was only marginally significant in MM. SNP rs79419269 close to gene SMARCD3 involved in chromatin remodeling was also significant (P=5.2 × 10-8). These data provide evidence for common genetic susceptibility to AL amyloidosis and MM. Cyclin D1 is a more prominent driver in AL amyloidosis than in MM, but the links to aggregation of light chains need to be demonstrated.


Subject(s)
Amyloidosis/genetics , Genome-Wide Association Study , Immunoglobulin Light Chains/metabolism , Multiple Myeloma/genetics , Adult , Aged , Aged, 80 and over , Cyclin D1/physiology , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide
6.
Nanoscale ; 7(21): 9835-43, 2015 Jun 07.
Article in English | MEDLINE | ID: mdl-25965406

ABSTRACT

Epitaxial double perovskite La2CoMnO6 (LCMO) films were grown by metalorganic aerosol deposition on SrTiO3(111) substrates. A high Curie temperature, TC = 226 K, and large magnetization close to saturation, MS(5 K) = 5.8µB/f.u., indicate a 97% degree of B-site (Co,Mn) ordering within the film. The Co/Mn ordering was directly imaged at the atomic scale by scanning transmission electron microscopy with energy-dispersive X-ray spectroscopy (STEM-EDX). Local electron-energy-loss spectroscopy (EELS) measurements reveal that the B-sites are predominantly occupied by Co(2+) and Mn(4+) ions in quantitative agreement with magnetic data. Relatively small values of the (1/2 1/2 1/2) superstructure peak intensity, obtained by X-ray diffraction (XRD), point out the existence of ordered domains with an arbitrary phase relationship across the domain boundary. The size of these domains is estimated to be in the range 35-170 nm according to TEM observations and modelling the magnetization data. These observations provide important information towards the complexity of the cation ordering phenomenon and its implications on magnetism in double perovskites, and similar materials.

7.
J Phys Condens Matter ; 26(45): 456003, 2014 Nov 12.
Article in English | MEDLINE | ID: mdl-25336527

ABSTRACT

We investigate the effect of electric current pulse injection on domain walls in La(0.7)Sr(0.3)MnO(3) (LSMO) half-ring nanostructures by high resolution x-ray magnetic microscopy at room temperature. Due to the easily accessible Curie temperature of LSMO, we can employ reasonable current densities to induce the Joule heating necessary to observe effects such as hopping of the domain walls between different pinning sites and nucleation/annihilation events. Such effects are the dominant features close to the Curie temperature, while spin torque is found to play a small role close to room temperature. We are also able to observe thermally activated domain wall transformations and we find that, for the analyzed geometries, the vortex domain wall configuration is energetically favored, in agreement with micromagnetic simulations.


Subject(s)
Lanthanum/chemistry , Magnetic Phenomena , Manganese Compounds/chemistry , Microscopy , Nanostructures/chemistry , Oxides/chemistry , Strontium/chemistry , Electric Conductivity , Temperature , X-Rays
8.
Micron ; 66: 9-15, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25080271

ABSTRACT

We describe a technique using a focused ion beam instrument to fabricate high quality plan-view specimens for transmission electron microscopy studies. The technique is simple, site-specific and is capable of fabricating multiple large, >100 µm(2) electron transparent windows within epitaxially grown thin films. A film of La0.67Sr0.33MnO3 is used to demonstrate the technique and its structural and functional properties are surveyed by high resolution imaging, electron spectroscopy, atomic force microscopy and Lorentz electron microscopy. The window is demonstrated to have good thickness uniformity and a low defect density that does not impair the film's Curie temperature. The technique will enable the study of in-plane structural and functional properties of a variety of epitaxial thin film systems.

9.
Article in German | MEDLINE | ID: mdl-22015796

ABSTRACT

Vibrio is a genus of bacteria present in surface and coastal waters as well as in marine organisms worldwide. In many countries, pathogenic Vibrio species are a main cause of bacterial diarrhea, which may result from comsumption of contaminated seafood and fish products or from drinking contaminated water. Vibrio infections may also gain in importance in our regions due to global warming and the increase in the world trade of seafood. The research network "VibrioNet" studies pathogenic Vibrios in the marine environment and in seafood consumed by humans as a potential, new emerging zoonotic agent. An assessment of the risk arising from pathogenic non-cholera-vibrios in central Europe is the target of a multidisciplinary research effort. The research network will be strengthened by cooperations with international partners from countries in which Vibrio infections play a major role (Bangladesh, Chile, India, Thailand, and Vietnam).


Subject(s)
Foodborne Diseases/microbiology , International Agencies , Seawater/microbiology , Vibrio Infections/microbiology , Vibrio Infections/transmission , Water Microbiology , Animals , Climate Change/statistics & numerical data , Cross-Sectional Studies , Developing Countries , Diarrhea/epidemiology , Diarrhea/microbiology , Europe , Fish Products/microbiology , Foodborne Diseases/epidemiology , Humans , Seafood/microbiology , Sepsis/epidemiology , Sepsis/microbiology , Sepsis/transmission , Vibrio Infections/epidemiology , Wound Infection/epidemiology , Wound Infection/microbiology , Wound Infection/transmission , Zoonoses/epidemiology , Zoonoses/microbiology , Zoonoses/transmission
10.
Neurology ; 59(8): 1139-45, 2002 Oct 22.
Article in English | MEDLINE | ID: mdl-12391340

ABSTRACT

OBJECTIVE: This prospective, randomized, controlled study was designed to investigate the safety, feasibility, and preliminary efficacy of long-term CSF drainage via a low-flow ventriculoperitoneal shunt in subjects suffering from AD. METHODS: Twenty-nine subjects selected for probable AD (National Institute of Neurological and Communicative Diseases and Stroke-Alzheimer's Disease and Related Dementias Association criteria) were screened to exclude normal pressure hydrocephalus or other etiologies of dementia and randomized to treatment (shunt) or no treatment groups. The study endpoint was the comparison of group performance on psychometric testing at quarterly intervals for 1 year. Shunted subjects had CSF withdrawn for MAP-tau and Abeta((1-42)) assays at the same time intervals. RESULTS: There was no mortality from the surgical procedure, and no patient sustained a subdural hematoma. Five notable postoperative adverse events, which resolved without permanent neurologic deficit, were reported in the shunt group. Group mean Mattis Dementia Rating Scale total scores showed little change over the year in the shunt-treatment group, in contrast to a decline in the control group (p = 0.06). Mini-Mental State Examination mean scores supported a trend in favor of shunt treatment (p = 0.1). There was a concomitant decrease in ventricular CSF concentrations of AD biomarkers MAP-tau and Abeta((1-42)). CONCLUSIONS: The surgical procedure and the device are reasonably safe. Adverse events were consistent with shunt procedures for hydrocephalus in this older population. The endpoint data show a trend in favor of the treated group. A larger, randomized, double-blinded, controlled, clinical trial is underway.


Subject(s)
Alzheimer Disease/surgery , Cerebrospinal Fluid Shunts/methods , Aged , Aged, 80 and over , Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/psychology , Cerebrospinal Fluid Shunts/adverse effects , Cerebrospinal Fluid Shunts/statistics & numerical data , Contraindications , Female , Follow-Up Studies , Humans , Linear Models , Male , Middle Aged , Neuropsychological Tests/statistics & numerical data , Pilot Projects , Prospective Studies
11.
Neurology ; 57(10): 1763-6, 2001 Nov 27.
Article in English | MEDLINE | ID: mdl-11723260

ABSTRACT

OBJECTIVE: To evaluate the production rate of CSF in patients with differing disease states. METHODS: The authors measured the production rate of CSF in three groups of patients: five patients with PD below age 60 (aged 51 +/- 4 years, mean +/- SD), nine with PD over age 60 (aged 69 +/- 6 years, mean +/- SD), and seven with dementia of the Alzheimer's type (AD) (aged 72 +/- 9 years, mean +/- SD). This method, based on the Masserman technique, employs ventricular rather than a lumbar access to the CSF space. Furthermore, the volume of CSF removed during the procedure is only 3 mL rather than 10 mL. RESULTS: These measurements indicate that the mean rate of CSF production in patients with PD under age 60 was 0.47 +/- 0.13 mL/minute, in patients with PD aged 60 or older the mean rate was 0.40 +/- 0.12 mL/minute, and in patients with AD the mean rate was 0.20 +/- 0.06 mL/minute. CONCLUSION: These results indicate that the rate of CSF production in patients with PD is normal, and that the rate of CSF production in patients with AD is markedly reduced.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Cerebrospinal Fluid/physiology , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Dementia/cerebrospinal fluid , Dementia/diagnosis , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Parkinson Disease/cerebrospinal fluid , Parkinson Disease/diagnosis , Reference Values , Secretory Rate/physiology
16.
Clin Cancer Res ; 5(6): 1435-43, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10389929

ABSTRACT

Glioblastoma multiforme (GM) is the most common and most malignant astrocytoma in adults. After surgery, radiation therapy extends patient survival; however, in vivo response to radiation therapy is variable. The purpose of this investigation was to determine whether the cytogenetic abnormalities of GM differ according to patient response to radiation therapy. Radiation response was defined by either progression [radiation-resistant (RR)] or resolution [radiation-sensitive (RS)] of tumor at the first postradiation radiographic imaging evaluation. Twenty RR and 10 RS frozen tissue specimens were subjected to cytogenetic analysis by comparative genomic hybridization. RS and RR specimens had different cytogenetic aberrations that mapped predominantly to chromosomes 7, 9, 10, 13, and 19. Relative gain of 7 occurred in 70% of the RR and 30% of the RS cases and was the most significant difference involving a single change between the two groups (P = 0.06). RR and RS specimens also differed in their patterns of simultaneous cytogenetic aberrations. A simultaneous gain of chromosomes 7 and 19 was found in 30% of the RR cases but was absent in the RS group. Concurrent loss of 9p23-24 and 13q14 regions was absent in the RS cohort but occurred in 30% of the RR series. This latter cytogenetic pattern was also associated with older age. Amplifications were more common in the RR series, but the difference did not reach statistical significance. The data suggest that GM with different in vivo responses to radiation therapy also differ cytogenetically.


Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/radiotherapy , Chromosome Aberrations/genetics , Glioblastoma/genetics , Glioblastoma/radiotherapy , Adult , Aged , Brain Neoplasms/mortality , Chromosome Disorders , Chromosome Mapping , Cohort Studies , Disease Progression , Female , Gene Amplification , Glioblastoma/mortality , Humans , Male , Middle Aged , Nucleic Acid Hybridization , Sequence Deletion , Survival Rate , Treatment Outcome
20.
J Neurooncol ; 37(2): 169-76, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9524096

ABSTRACT

Chemotherapeutic regimens in present use for recurrent glioma have substantial toxicity. Activity against recurrent gliomas has been reported for both tamoxifen and interferon alpha, agents that have more acceptable toxicity profiles and that can be administered in an outpatient setting. We tested the efficacy and toxicity of the combination of high-dose tamoxifen and interferon alpha in adults with recurrent glioma in a phase II trial. Eligible patients had radiographically measurable recurrent gliomas of any grade after initial radiation therapy. Interferon-alpha [6 x 10(6) U subcutaneously three times per week] and tamoxifen (240 mg/m2/day orally) were administered continuously. Treatment response was assessed at 6 week intervals using clinical and radiographic criteria. Eighteen patients (11 males and 7 females) were enrolled. Median age was 41 years (range 23-61 years). All patients had gliomas that progressed after radiation therapy and nitrosourea chemotherapy. The histologic diagnosis of the original tumor was glioblastoma multiforme in 8 patients, anaplastic astrocytoma in 5 patients, astrocytoma in 4 patients and mixed malignant glioma in 1 patient. Reversible moderate to severe neurological toxicity manifested by dizziness and unsteady gait was seen at tamoxifen doses of 240 mg/m2/day. Although the initial tamoxifen dose was reduced to 120 mg/m2/day, moderate neurotoxicity was noted at this dose as well and the trial was closed early. The combination of oral tamoxifen (120 to 240 mg/m2/day) and subcutaneous interferon-alpha [6 x 10(6) U three times per week] was associated with significant neurotoxicity in this group of recurrent glioma patients, resulting in early study closure. Of 16 evaluable patients, 12 had progressive disease after one cycle of treatment, 3 had stable disease, and there was one minor response. Gradual dose escalation may be required if similar patients are to be treated with high dose tamoxifen in conjunction with interferon.


Subject(s)
Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents/administration & dosage , Brain Neoplasms/therapy , Glioma/therapy , Interferon-alpha/administration & dosage , Tamoxifen/administration & dosage , Administration, Oral , Adult , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Antineoplastic Agents, Hormonal/adverse effects , Antineoplastic Agents, Hormonal/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Injections, Subcutaneous , Interferon alpha-2 , Interferon-alpha/adverse effects , Interferon-alpha/therapeutic use , Male , Middle Aged , Neoplasm Recurrence, Local , Recombinant Proteins , Survival Analysis , Tamoxifen/adverse effects , Tamoxifen/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...